| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |